Skip to main content

MARSHALL WACE, LLP

Position in ELV — Elevance Health, Inc.

CIK 1318757 LONDON, X0

Position in ELV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,127,517
+$7,015,068 QoQ
Shares Held
21,016
+453.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#383
of 1,597 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ELV Over Time

Shares Held

Position Value (USD)

Derivatives in ELV

reported options exposure · as of Sep 30, 2025
CallValue
$32,312
CallShares
100
PutValue
$64,268,568
PutShares
198,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Healthcare Plans

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $1,202,539,993 across 11 Healthcare Plans names. ELV ranks #10 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ELV

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,127,517 21,016
2026-03-31 $1,112,449 3,800
2025-09-30 $32,312 100
2025-09-30 $11,586,113 35,857
2025-09-30 $64,268,568 198,900
2024-06-30 $35,762,760 66,000
2023-12-31 $61,059,002 129,483
2023-09-30 $198,043,384 454,833
2023-06-30 $236,848,776 533,095
2023-03-31 $250,902,223 545,665
2022-12-31 $188,079,936 366,649
2021-12-31 $225,677,693 486,857
2021-09-30 $22,929,436 61,506
2021-06-30 $25,829,533 67,652
2021-03-31 $68,572,731 191,037
2020-12-31 $76,320,524 237,692
2020-09-30 $47,060,728 175,214
2020-06-30 $14,716,097 55,959
2020-03-31 $19,132,887 84,271